HEADER OXYGEN TRANSPORT 31-MAR-94 1PGH OBSLTE 30-NOV-94 1PGH 2PGH TITLE STRUCTURE OF PORCINE HEMOGLOBIN AT 2.8 ANGSTROMS RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE:; COMPND 7 CHAIN: B, D; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 MOL_ID: 2 KEYWDS OXYGEN TRANSPORT EXPDTA X-RAY DIFFRACTION AUTHOR D.S.KATZ,S.P.WHITE,W.HUANG,R.KUMAR,D.W.CHRISTIANSON REVDAT 2 30-NOV-94 1PGH 3 OBSLTE REVDAT 1 22-JUN-94 1PGH 0 JRNL AUTH D.S.KATZ,S.P.WHITE,W.HUANG,R.KUMAR,D.W.CHRISTIANSON JRNL TITL STRUCTURE OF PORCINE HEMOGLOBIN AT 2.8 ANGSTROMS JRNL TITL 2 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.K.O'DONNELL,M.J.MARTIN,J.S.LOGAN,R.KUMAR REMARK 1 TITL PRODUCTION OF HEMOGLOBIN IN TRANSGENIC SWINE: AN REMARK 1 TITL 2 APPROACH TO A BLOOD SUBSTITUTE REMARK 1 REF CANCER DETECT.PREV. V. 17 307 1993 REMARK 1 REFN ASTM CDPRD4 US ISSN 0361-090X REMARK 1 REFERENCE 2 REMARK 1 AUTH C.J.LEE,P.KAN,W.K.CHEN REMARK 1 TITL THE PURIFICATION AND COMPARATIVE ANALYSIS OF REMARK 1 TITL 2 HEMOGLOBIN FROM ANIMAL BLOODS REMARK 1 REF BIOMATER.,ARTIF.CELLS, V. 20 477 1992 REMARK 1 REF 2 IMMOBILIZATION BIOTECHNOL. REMARK 1 REFN ASTM BACBEU US ISSN 1055-7172 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.E.SWANSON,M.J.MARTIN,J.K.O'DONNELL,K.HOOVER, REMARK 1 AUTH 2 W.SAGO,V.HUNTRESS,C.T.PARSONS,C.A.PINKERT,S.PILDER, REMARK 1 AUTH 3 J.S.LOGAN REMARK 1 TITL PRODUCTION OF FUNCTIONAL HUMAN HEMOGLOBIN IN REMARK 1 TITL 2 TRANSGENIC SWINE REMARK 1 REF BIO(SLASH)TECHNOLOGY V. 10 557 1992 REMARK 1 REFN ASTM BTCHDA US ISSN 0733-222X REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 1PGH REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 8800 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.143 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 172 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.90 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PGH COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1PGH THE DEPOSITOR CONCLUDE THAT THEIR CRYSTALS ARE OF REMARK 5 AQUOMET 1PGH FORM BECAUSE: 1PGH A) PRECAUTIONS SIMILAR TO REMARK 5 THOSE USED IN THE CRYSTALLIZATION 1PGH OF HUMAN REMARK 5 OXYHEMOGLOBIN (E.G., ADDITION OF CHELATING 1PGH AGENTS OR REMARK 5 BUBBLING OXYGEN INTO SOLUTIONS) WERE NOT USED. 1PGH B) REMARK 5 OXYHEMOGLOBIN AUTOOXIDIZES TO AQUOMET HEMOGLOBIN WITHOUT REMARK 5 1PGH SUCH PRECAUTIONS. 1PGH C) RE-DISSOLVED CRYSTALS REMARK 5 EXHIBIT AN ABSORBANCE SPECTRUM 1PGH CHARACTERISTIC OF THE REMARK 5 AQUOMET FORM (MAXIMUM = 405 NM). 1PGH HOWEVER, SOLVENT REMARK 5 MOLECULES THAT COORDINATES TO EACH FE ATOM 1PGH ARE NOT REMARK 5 APPARENT. 1PGH REMARK 6 REMARK 6 1PGH CORRECTION. THIS ENTRY IS OBSOLETE. 30-NOV-94. 1PGH REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.90000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.90000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 4 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 50 CB HIS A 50 CG 0.070 REMARK 500 HIS C 72 CB HIS C 72 CG 0.076 REMARK 500 HIS C 113 CB HIS C 113 CG 0.089 REMARK 500 HIS C 113 CG HIS C 113 CD2 0.079 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 48 N - CA - C ANGL. DEV. = 14.8 DEGREES REMARK 500 HIS A 72 CA - CB - CG ANGL. DEV. = 15.3 DEGREES REMARK 500 HIS A 89 CA - CB - CG ANGL. DEV. = 17.4 DEGREES REMARK 500 HIS A 89 CB - CG - CD2 ANGL. DEV. =-12.8 DEGREES REMARK 500 HIS A 113 CA - CB - CG ANGL. DEV. = 26.8 DEGREES REMARK 500 LEU B 14 CA - CB - CG ANGL. DEV. = 13.7 DEGREES REMARK 500 LEU B 75 N - CA - C ANGL. DEV. =-12.1 DEGREES REMARK 500 HIS B 77 CA - CB - CG ANGL. DEV. = 18.4 DEGREES REMARK 500 HIS B 146 CA - C - O ANGL. DEV. = 13.3 DEGREES REMARK 500 HIS C 113 CA - CB - CG ANGL. DEV. = 37.2 DEGREES REMARK 500 HIS D 97 CA - CB - CG ANGL. DEV. = 13.7 DEGREES REMARK 500 HIS D 120 ND1 - CG - CD2 ANGL. DEV. = 12.7 DEGREES REMARK 500 HIS D 120 CG - ND1 - CE1 ANGL. DEV. =-13.6 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS B 76 -44.19 83.11 REMARK 500 SER C 81 -75.99 35.17 REMARK 525 REMARK 525 SOLVENT REMARK 525 THE FOLLOWING SOLVENT MOLECULES LIE FARTHER THAN EXPECTED REMARK 525 FROM THE PROTEIN OR NUCLEIC ACID MOLECULE AND MAY BE REMARK 525 ASSOCIATED WITH A SYMMETRY RELATED MOLECULE (M=MODEL REMARK 525 NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH 29 DISTANCE = 7.65 ANGSTROMS REMARK 525 HOH 30 DISTANCE = 5.68 ANGSTROMS REMARK 525 HOH 54 DISTANCE = 6.29 ANGSTROMS REMARK 525 HOH 98 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH 105 DISTANCE = 7.93 ANGSTROMS REMARK 525 HOH 108 DISTANCE = 7.30 ANGSTROMS REMARK 525 HOH 111 DISTANCE = 5.53 ANGSTROMS REMARK 525 HOH 117 DISTANCE = 7.41 ANGSTROMS REMARK 525 HOH 122 DISTANCE = 9.59 ANGSTROMS REMARK 525 HOH 124 DISTANCE = 5.96 ANGSTROMS REMARK 525 HOH 125 DISTANCE = 8.31 ANGSTROMS REMARK 525 HOH 129 DISTANCE = 7.59 ANGSTROMS REMARK 525 HOH 130 DISTANCE = 6.95 ANGSTROMS REMARK 525 HOH 149 DISTANCE = 5.40 ANGSTROMS REMARK 525 HOH 150 DISTANCE = 6.18 ANGSTROMS REMARK 525 HOH 151 DISTANCE = 5.51 ANGSTROMS REMARK 525 HOH 154 DISTANCE = 5.41 ANGSTROMS REMARK 525 HOH 156 DISTANCE = 6.05 ANGSTROMS REMARK 525 HOH 157 DISTANCE = 9.73 ANGSTROMS REMARK 525 HOH 158 DISTANCE = 5.73 ANGSTROMS REMARK 525 HOH 161 DISTANCE = 9.81 ANGSTROMS SEQRES 1 A 141 VAL LEU SER ALA ALA ASP LYS ALA ASN VAL LYS ALA ALA SEQRES 2 A 141 TRP GLY LYS VAL GLY GLY GLN ALA GLY ALA HIS GLY ALA SEQRES 3 A 141 GLU ALA LEU GLU ARG MET PHE LEU GLY PHE PRO THR THR SEQRES 4 A 141 LYS THR TYR PHE PRO HIS PHE ASN LEU SER HIS GLY SER SEQRES 5 A 141 ASP GLN VAL LYS ALA HIS GLY GLN LYS VAL ALA ASP ALA SEQRES 6 A 141 LEU THR LYS ALA VAL GLY HIS LEU ASP ASP LEU PRO GLY SEQRES 7 A 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 A 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 A 141 LEU LEU VAL THR LEU ALA ALA HIS HIS PRO ASP ASP PHE SEQRES 10 A 141 ASN PRO SER VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 A 141 ASN VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 B 146 VAL HIS LEU SER ALA GLU GLU LYS GLU ALA VAL LEU GLY SEQRES 2 B 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 B 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER ASN ALA ASP SEQRES 5 B 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 B 146 LYS VAL LEU GLN SER PHE SER ASP GLY LEU LYS HIS LEU SEQRES 7 B 146 ASP ASN LEU LYS GLY THR PHE ALA LYS LEU SER GLU LEU SEQRES 8 B 146 HIS CYS ASP GLN LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 B 146 LEU LEU GLY ASN VAL ILE VAL VAL VAL LEU ALA ARG ARG SEQRES 10 B 146 LEU GLY HIS ASP PHE ASN PRO ASP VAL GLN ALA ALA PHE SEQRES 11 B 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 B 146 LYS TYR HIS SEQRES 1 C 141 VAL LEU SER ALA ALA ASP LYS ALA ASN VAL LYS ALA ALA SEQRES 2 C 141 TRP GLY LYS VAL GLY GLY GLN ALA GLY ALA HIS GLY ALA SEQRES 3 C 141 GLU ALA LEU GLU ARG MET PHE LEU GLY PHE PRO THR THR SEQRES 4 C 141 LYS THR TYR PHE PRO HIS PHE ASN LEU SER HIS GLY SER SEQRES 5 C 141 ASP GLN VAL LYS ALA HIS GLY GLN LYS VAL ALA ASP ALA SEQRES 6 C 141 LEU THR LYS ALA VAL GLY HIS LEU ASP ASP LEU PRO GLY SEQRES 7 C 141 ALA LEU SER ALA LEU SER ASP LEU HIS ALA HIS LYS LEU SEQRES 8 C 141 ARG VAL ASP PRO VAL ASN PHE LYS LEU LEU SER HIS CYS SEQRES 9 C 141 LEU LEU VAL THR LEU ALA ALA HIS HIS PRO ASP ASP PHE SEQRES 10 C 141 ASN PRO SER VAL HIS ALA SER LEU ASP LYS PHE LEU ALA SEQRES 11 C 141 ASN VAL SER THR VAL LEU THR SER LYS TYR ARG SEQRES 1 D 146 VAL HIS LEU SER ALA GLU GLU LYS GLU ALA VAL LEU GLY SEQRES 2 D 146 LEU TRP GLY LYS VAL ASN VAL ASP GLU VAL GLY GLY GLU SEQRES 3 D 146 ALA LEU GLY ARG LEU LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG PHE PHE GLU SER PHE GLY ASP LEU SER ASN ALA ASP SEQRES 5 D 146 ALA VAL MET GLY ASN PRO LYS VAL LYS ALA HIS GLY LYS SEQRES 6 D 146 LYS VAL LEU GLN SER PHE SER ASP GLY LEU LYS HIS LEU SEQRES 7 D 146 ASP ASN LEU LYS GLY THR PHE ALA LYS LEU SER GLU LEU SEQRES 8 D 146 HIS CYS ASP GLN LEU HIS VAL ASP PRO GLU ASN PHE ARG SEQRES 9 D 146 LEU LEU GLY ASN VAL ILE VAL VAL VAL LEU ALA ARG ARG SEQRES 10 D 146 LEU GLY HIS ASP PHE ASN PRO ASP VAL GLN ALA ALA PHE SEQRES 11 D 146 GLN LYS VAL VAL ALA GLY VAL ALA ASN ALA LEU ALA HIS SEQRES 12 D 146 LYS TYR HIS HET HEM A 1 43 HET HEM B 1 43 HET HEM C 1 43 HET HEM D 1 43 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 5 HEM 4(C34 H32 FE N4 O4) FORMUL 9 HOH *162(H2 O1) HELIX 1 AA SER A 3 GLY A 18 1 16 HELIX 2 AB GLN A 20 GLY A 35 1 16 HELIX 3 AC PHE A 36 TYR A 42 1 7 HELIX 4 AE SER A 52 GLY A 71 1 20 HELIX 5 AF LEU A 80 ALA A 88 1 9 HELIX 6 AG ASP A 94 HIS A 112 1 19 HELIX 7 AH ASN A 118 SER A 138 1 21 HELIX 8 BA SER B 4 VAL B 18 1 15 HELIX 9 BB ASN B 19 VAL B 34 1 16 HELIX 10 BC TYR B 35 PHE B 41 1 7 HELIX 11 BD ASN B 50 GLY B 56 1 7 HELIX 12 BE ASN B 57 LYS B 76 1 20 HELIX 13 BF PHE B 85 CYS B 93 1 9 HELIX 14 BG ASP B 99 ARG B 117 1 19 HELIX 15 BH ASN B 123 HIS B 143 1 21 HELIX 16 CA SER C 3 GLY C 18 1 16 HELIX 17 CB GLN C 20 GLY C 35 1 16 HELIX 18 CC PHE C 36 TYR C 42 1 7 HELIX 19 CE SER C 52 GLY C 71 1 20 HELIX 20 CF LEU C 80 ALA C 88 1 9 HELIX 21 CG ASP C 94 HIS C 112 1 19 HELIX 22 CH ASN C 118 SER C 138 1 21 HELIX 23 DA SER D 4 VAL D 18 1 15 HELIX 24 DB ASN D 19 VAL D 34 1 16 HELIX 25 DC TYR D 35 PHE D 41 1 7 HELIX 26 DD ASN D 50 GLY D 56 1 7 HELIX 27 DE ASN D 57 LYS D 76 1 20 HELIX 28 DF PHE D 85 CYS D 93 1 9 HELIX 29 DG ASP D 99 ARG D 117 1 19 HELIX 30 DH ASN D 123 HIS D 143 1 21 CRYST1 69.600 72.800 115.800 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014368 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013736 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008636 0.00000